Savara Inc. (SVRA) - Latest Market Data

Price & Market Data

Price: $3.27

Daily Change: $0.00 / 0.00%

Range: $0 - $0

Market Cap: $564,509,888

Volume: 0

Performance Metrics

1 Week: 11.60%

1 Month: 18.05%

3 Months: 13.54%

6 Months: -8.40%

1 Year: -30.43%

YTD: 6.51%

Company Details

Employees: 59

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Langhorne, Pennsylvania.

Selected stocks

United States Cellular Corporation 5.500% Senior Notes due 2070 (UZF)

United States Cellular Corporation 5.500% Senior Notes due 2070 (UZE)

Sensata Technologies Holding plc (ST)